298 related articles for article (PubMed ID: 31700869)
1. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis.
Wang Y; Li Y; Chen P; Xu W; Wu Y; Che G
Ann Transl Med; 2019 Sep; 7(18):433. PubMed ID: 31700869
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
4. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
Meng L; Yang Y; Hu X; Zhang R; Li X
J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
Li X; Zhang S; Lu J; Li C; Li N
Front Surg; 2022; 9():922595. PubMed ID: 36090319
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer.
Li J; Shao J; Zhang X; Chen X; Zhao W; Qian H; Cui X; Jiang X
Gastroenterol Res Pract; 2020; 2020():8781674. PubMed ID: 33293949
[TBL] [Abstract][Full Text] [Related]
10. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between Systemic Immune Inflammatory Index and Prognosis of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review.
Huang W; Luo J; Wen J; Jiang M
Front Surg; 2022; 9():898304. PubMed ID: 35846963
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
13. Systemic immune-inflammation index and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta-analysis.
Li D; Zhao X; Pi X; Wang K; Song D
Clin Exp Med; 2023 Oct; 23(6):2105-2114. PubMed ID: 36287310
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.
Wang Z; Zhan P; Lv Y; Shen K; Wei Y; Liu H; Song Y
Transl Lung Cancer Res; 2019 Jun; 8(3):214-226. PubMed ID: 31367535
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
[No Abstract] [Full Text] [Related]
17. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
18. High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis.
Xu S; Cao S; Yu Y
J Cancer Res Ther; 2021 Dec; 17(7):1636-1642. PubMed ID: 35381733
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.
Zhang B; Yao W
World J Surg Oncol; 2022 Sep; 20(1):320. PubMed ID: 36171621
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis.
Zhou Y; Dai M; Zhang Z
Front Oncol; 2022; 12():814727. PubMed ID: 35186750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]